Skip to main content

Advertisement

Log in

Role of NR1I2 (pregnane X receptor) polymorphisms in head and neck squamous cell carcinoma

Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

The pregnane X receptor (PXR) is a transcription factor regulating genes involved not only in pharmacokinetics but also in chemotherapy resistance and cancer progression. The significance of PXR for survival of head and neck squamous cell carcinoma (HNSCC) patients is unknown so far. Single nucleotide polymorphisms (SNPs) in the PXR-encoding NR1I2 gene influence receptor functionality and inducibility by ligands and thus modulate expression and activity of its target genes. In this study, seven SNPs in the NR1I2 gene were investigated for an association with PXR protein expression and survival of HNSCC patients. Genotyping was conducted using hybridisation probe format methodology. PXR protein expression was quantified by immunohistochemistry of tissue microarray samples of HNSCC biopsies. Genotypes were correlated to PXR protein expression by a linear model regressing on the continuous gene expression value and a Cox model regressing on overall survival times. Haplotype analysis was performed by reconstruction of haplotypes from genotype information according to the expectation-maximisation algorithm. Of all tested SNPs, rs1054190 and rs1054191 allele variants tended to correlate with a reduced protein expression score of PXR (p = 0.088). Four haplotypes, each consisting of two SNPs, rs3814055/rs1054190 and rs3814055/rs1054191 as well as rs1523127/rs1054190 and rs1523127/rs1054191, showed a significant reduction of the PXR expression score (p = 0.049 and p = 0.032). However, neither allele variants nor haplotypes influenced overall survival of the respective patients. Certain NR1I2 SNPs showed an impact on PXR protein expression in HNSCC but did not influence overall survival times, questioning their value as prognostic biomarkers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Andersen V, Christensen J, Ernst A, Jacobsen BA, Tjonneland A, Krarup HB, Vogel U (2011) Polymorphisms in NF-kappaB, PXR, LXR, PPARgamma and risk of inflammatory bowel disease. World J Gastroenterol 17:197–206

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265

    Article  CAS  PubMed  Google Scholar 

  • Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Backman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A (1998) Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci U S A 95:12208–12213

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Conde I, Lobo MV, Zamora J, Perez J, Gonzalez FJ, Alba E, Fraile B, Paniagua R, Arenas MI (2008) Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha. BMC Cancer 8:174

    Article  PubMed Central  PubMed  Google Scholar 

  • Fan CY (2001) Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair. Curr Oncol Rep 3:66–71

    Article  CAS  PubMed  Google Scholar 

  • Fanucchi M, Khuri FR (2004) Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck. Semin Oncol 2004:809–815

    Article  Google Scholar 

  • Fujimura T, Takahashi S, Urano T, Tanaka T, Zhang W, Azuma K, Takayama K, Obinata D, Murata T, Horie-Inoue K, Kodama T, Ouchi Y, Homma Y, Inoue S (2012) Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer. Cancer Sci 103:176–180

    Article  CAS  PubMed  Google Scholar 

  • Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229

    Article  CAS  PubMed  Google Scholar 

  • Gardner-Stephen D, Heydel JM, Goyal A, Lu Y, Xie W, Lindblom T, Mackenzie P, Radominska-Pandya A (2004) Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metab Dispos 32:340–347

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98

    CAS  Google Scholar 

  • Harmsen S, Meijerman I, Beijnen JH, Schellens JH (2009) Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor. Cancer Chemother Pharmacol 64:35–43

    Article  CAS  PubMed  Google Scholar 

  • Harmsen S, Meijerman I, Febus CL, Maas-Bakker RF, Beijnen JH, Schellens JH (2010) PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line. Cancer Chemother Pharmacol 66:765–771

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, Zöller J, Bosch FX, Zöller M (1996) Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 179:66–73

    Article  CAS  PubMed  Google Scholar 

  • Jiang H, Chen K, He J, Pan F, Li J, Chen J, Chen W, Liang H (2009) Association of pregnane X receptor with multidrug resistance-related protein 3 and its role in human colon cancer chemoresistance. J Gastrointest Surg 13:1831–1838

    Article  PubMed  Google Scholar 

  • Karlsen TH, Lie BA, Frey Froslie K, Thorsby E, Broome U, Schrumpf E, Boberg KM (2006) Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis. Gastroenterology 131:781–787

    Article  CAS  PubMed  Google Scholar 

  • Kaskas NM, Moore-Medlin T, McClure GB, Ekshyyan O, Vanchiere JA, Nathan CA (2014) Serum biomarkers in head and neck squamous cell cancer. JAMA Otolaryngol Head Neck Surg 140:5–11

    Article  PubMed  Google Scholar 

  • King CR, Xiao M, Yu J, Minton MR, Addleman NJ, Van Booven DJ, Kwok PY, McLeod HL, Marsh S (2007) Identification of NR1I2 genetic variation using resequencing. Eur J Clin Pharmacol 63:547–554

    Article  CAS  PubMed  Google Scholar 

  • Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterström RH, Perlmann T, Lehmann JM (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73–82

    Article  CAS  PubMed  Google Scholar 

  • Kodama S, Negishi M (2011) Pregnane X receptor PXR activates the GADD45beta gene, eliciting the p38 MAPK signal and cell migration. J Biol Chem 286:3570–3578

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • König SK, Herzog M, Theile D, Zembruski N, Haefeli WE, Weiss J (2010) Impact of drug transporters on cellular resistance towards saquinavir and darunavir. J Antimicrob Chemother 65:2319–2328

  • Kotta-Loizou I, Patsouris E, Theocharis S (2013) Pregnane X receptor polymorphisms associated with human diseases. Expert Opin Ther Targets 17:1167–1177

    Article  CAS  PubMed  Google Scholar 

  • Lamba J, Lamba V, Strom S, Venkataramanan R, Schuetz E (2008) Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression. Drug Metab Dispos 36:169–181

    Article  CAS  PubMed  Google Scholar 

  • Lodish H, Berk A, Zipursky SL (2000) Molecular cell biology, 4th edn. W. H. Freeman, New York

    Google Scholar 

  • MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (Risk M-GCoGSfMHTRBC) (2010) Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy. Int J Cancer 126:2935–2946

    Google Scholar 

  • Masuyama H, Hiramatsu Y, Kodama J, Kudo T (2003) Expression and potential roles of pregnane X receptor in endometrial cancer. J Clin Endocrinol Metab 88:4446–4454

    Article  CAS  PubMed  Google Scholar 

  • Meyer zu Schwabedissen HE, Kim RB (2009) Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms. Mol Pharm 6:1644–1661

    Article  CAS  PubMed  Google Scholar 

  • Miki Y, Suzuki T, Kitada K, Yabuki N, Shibuya R, Moriya T, Ishida T, Ohuchi N, Blumberg B, Sasano H (2006) Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res 66:535–542

    Article  CAS  PubMed  Google Scholar 

  • Pondugula SR, Brimer-Cline C, Wu J, Schuetz EG, Tyagi RK, Chen T (2009) A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor. Drug Metab Dispos 37:719–730

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Qiao E, Ji M, Wu J, Ma R, Zhang X, He Y, Zha Q, Song X, Zhu LW, Tang J (2013) Expression of the PXR gene in various types of cancer and drug resistance. Oncol Lett 5:1093–1100

    PubMed Central  CAS  PubMed  Google Scholar 

  • Rigalli JP, Ruiz ML, Perdomo VG, Villanueva SS, Mottino AD, Catania VA (2011) Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells. Toxicology 285:18–24

    Article  CAS  PubMed  Google Scholar 

  • Rigalli JP, Reuter T, Herold-Mende C, Dyckhoff G, Haefeli WE, Weiss J, Theile D (2013) Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro. Cancer Chemother Pharmacol 71:1335–1343

    Article  CAS  PubMed  Google Scholar 

  • Rothenberg SM, Ellisen LW (2012) The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Invest 122:1951–1957

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rousseau AB (2012) Head and neck: squamous cell carcinoma: an overview. Atlas Genet Cytogenet Oncol Haematol 16:145–155

    Google Scholar 

  • Sinnwell JP, Schaid DJ (2013) Haplo.Stats: statistical analysis of haplotypes with traits and covariates when linkage phase is ambiguous. R Packag Vers 168:ed2013

    Google Scholar 

  • Sookoian S, Castano GO, Burgueno AL, Gianotti TF, Rosselli MS, Pirola CJ (2010) The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease. Pharmacogenet Genomics 20:1–8

    Article  CAS  PubMed  Google Scholar 

  • Svard J, Spiers JP, Mulcahy F, Hennessy M (2010) Nuclear receptor-mediated induction of CYP450 by antiretrovirals: functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and Sub-Saharan Africans. J Acquir Immune Defic Syndr 55:536–549

    Article  PubMed  Google Scholar 

  • Synold TW, Dussault I, Forman BM (2001) The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7:584–590

    Article  CAS  PubMed  Google Scholar 

  • Takeyama D, Miki Y, Fujishima F, Suzuki T, Akahira J, Hata S, Miyata G, Satomi S, Sasano H (2010) Steroid and xenobiotic receptor in human esophageal squamous cell carcinoma: a potent prognostic factor. Cancer Sci 101:543–549

    Article  CAS  PubMed  Google Scholar 

  • Theile D, Ketabi-Kiyanvash N, Herold-Mende C, Dyckhoff G, Efferth T, Bertholet V, Haefeli WE, Weiss J (2011) Evaluation of drug transporters’ significance for multidrug resistance in head and neck squamous cell carcinoma. Head Neck 33:959–968

    Article  PubMed  Google Scholar 

  • Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034

    Article  PubMed Central  PubMed  Google Scholar 

  • Wang H, Venkatesh M, Li H, Goetz R, Mukherjee S, Biswas A, Zhu L, Kaubisch A, Wang L, Pullman J, Whitney K, Kuro-o M, Roig AI, Shay JW, Mohammadi M, Mani S (2011) Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. J Clin Invest 121:3220–3232

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Warta R, Theile D, Mogler C, Herpel E, Grabe N, Lahrmann B, Plinkert PK, Herold-Mende C, Weiss J, Dyckhoff G (2014) Association of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinoma. PLoS ONE 9, e108908

    Article  PubMed Central  PubMed  Google Scholar 

  • Weber A, Tannapfel A, Wittekind C, Bootz F (2002) Carcinogen-induced site-specific mutagenesis and genetic susceptibility in squamous cell carcinoma of the head and neck. Onkologie 25:8–13

    Article  CAS  PubMed  Google Scholar 

  • Yue X, Akahira J, Utsunomiya H, Miki Y, Takahashi N, Niikura H, Ito K, Sasano H, Okamura K, Yaegashi N (2010) Steroid and xenobiotic receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer. Pathol Int 60:400–406

    Article  PubMed  Google Scholar 

  • Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Wrighton SA, Hancock M, Kim RB, Strom S, Thummel K, Russell CG, Hudson JR Jr, Schuetz EG, Boguski MS (2001) The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 11:555–572

    Article  CAS  PubMed  Google Scholar 

  • Zhang B, Xie W, Krasowski MD (2008) PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics 9:1695–1709

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zhang XC, Xu C, Mitchell RM, Zhang B, Zhao D, Li Y, Huang X, Fan W, Wang H, Lerma LA, Upton MP, Hay A, Méndez E, Zhao LP (2013) Tumor evolution and intratumor heterogeneity of an oropharyngeal squamous cell carcinoma revealed by whole-genome sequencing. Neoplasia 15:1371–1378

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This project was partly funded by grant WE 4135/3-1 und HE 2357/2-1 from the German Research Foundation. We thank Dr. Justo Lorenzo Bermejo for his statistical advice during the haplotype analysis.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johanna Weiss.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reuter, T., Warta, R., Theile, D. et al. Role of NR1I2 (pregnane X receptor) polymorphisms in head and neck squamous cell carcinoma. Naunyn-Schmiedeberg's Arch Pharmacol 388, 1141–1150 (2015). https://doi.org/10.1007/s00210-015-1150-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-015-1150-1

Keywords

Navigation